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Ever since the seminal work that was published by Perou
et al., triple-negative breast cancer (TNBC) has become a
commonlexiconamongclinicianswhocareforpatientswith
breast cancer. Beside portending a poor outcome, TNBC
is unique in that, unlike the hormone-positive and Her-2-
positive cancer cells, it lacks target speciﬁc therapy. This is
likely the result of our lack of having a clear understanding
of its biology.
In this special issue, we were highly selective of only
papers that we thought might further advance our under-
standingofthedisease.Thus,thepapersvarywidelyfromthe
role of race/ethnicity to the metabolic/molecular inﬂuence
that can potentially impact the biology of the disease.
We hope that this special issue will serve as a focal point
to continue our ongoing discussion about this challenging
entity.
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